WTR is a unique and timely intelligence service informing commercial trademark decision making by assessing the business impact of trademark law developments.

Pharmaceutical companies face increasing pressure to demonstrate not only the efficacy of their treatments, but also the impact of these treatments on patients' lives. This interest in and the ...

A second protocol defined interim analysis is planned when approximately 50% (or 55) HBeAg+ participants complete 24 weeks of the treatment period. This enrollment milestone occurred in January 2026.

This encyclopedic article outlines evidence-based laboratory tests that are most useful for establishing individualized ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The FDA released a draft guidance document that provides a regulatory framework for sponsors to utilize minimal residual ...

Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and management across the full HF spectrum remain incompletely characterised. Methods ...

Rubrik, Inc. ( RBRK) Data Recovery Summit January 21, 2026 1:00 PM EST ...

Explore the top 7 Cloud Security Posture Management (CSPM) tools for CIOs in 2026, designed to protect against cloud misconfigurations, optimize security posture, and support compliance across ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

Adversaries are increasingly targeting third-party providers, catching customer companies on their heels. CISOs must play a larger role in vendor negotiations — and get tougher about what they ask.